a trend towards significancep = 0.053
For secondary endpoints, at week 12, 82% of subjects in the treatment group achieved complete closure (18 of 22) versus 53% in the control group (9 of 17), with a trend towards significance ( p = 0.053).
For secondary endpoints, at week 12, 82% of subjects in the treatment group achieved complete closure (18 of 22) versus 53% in the control group (9 of 17), with a trend towards significance ( p = 0.053).
However, a positive trend was noted in NIHSS scores, with a median score of 3 (IQR: 3–6.75) in the AASCs group compared to 7 (IQR: 0–12.5) in the placebo group at 24 months.